BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 9951596)

  • 41. Fine needle aspiration biopsy cytology of phyllodes tumour and fibroadenoma: A cytomorphological study of 104 cases.
    Wang XY; Mahajan H; Dickinson N; Cox C; Byth K; Bayly A; Cahill MA; Pathmanathan N
    Diagn Cytopathol; 2018 Nov; 46(11):927-935. PubMed ID: 30284391
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Core needle biopsy diagnosis of fibroepithelial lesions of the breast: a diagnostic challenge.
    Li JJX; Tse GM
    Pathology; 2020 Oct; 52(6):627-634. PubMed ID: 32771211
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: long-term outcome of 36 malignant phyllodes tumors.
    Abe M; Miyata S; Nishimura S; Iijima K; Makita M; Akiyama F; Iwase T
    Breast Cancer; 2011 Oct; 18(4):268-72. PubMed ID: 22121516
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Significant histologic features differentiating cellular fibroadenoma from phyllodes tumor on core needle biopsy specimens.
    Yasir S; Gamez R; Jenkins S; Visscher DW; Nassar A
    Am J Clin Pathol; 2014 Sep; 142(3):362-9. PubMed ID: 25125627
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sonographic features of phyllodes tumors of the breast.
    Chao TC; Lo YF; Chen SC; Chen MF
    Ultrasound Obstet Gynecol; 2002 Jul; 20(1):64-71. PubMed ID: 12100421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phyllodes tumours of the breast: a consensus review.
    Tan BY; Acs G; Apple SK; Badve S; Bleiweiss IJ; Brogi E; Calvo JP; Dabbs DJ; Ellis IO; Eusebi V; Farshid G; Fox SB; Ichihara S; Lakhani SR; Rakha EA; Reis-Filho JS; Richardson AL; Sahin A; Schmitt FC; Schnitt SJ; Siziopikou KP; Soares FA; Tse GM; Vincent-Salomon A; Tan PH
    Histopathology; 2016 Jan; 68(1):5-21. PubMed ID: 26768026
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Second harmonic generation microscopy is a novel technique for differential diagnosis of breast fibroepithelial lesions.
    Tan WJ; Yan J; Xu S; Thike AA; Bay BH; Yu H; Tan MH; Tan PH
    J Clin Pathol; 2015 Dec; 68(12):1033-5. PubMed ID: 26209730
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Platelet-derived growth factor expression in phyllodes tumors and fibroadenomas of the breast.
    Feakins RM; Wells CA; Young KA; Sheaff MT
    Hum Pathol; 2000 Oct; 31(10):1214-22. PubMed ID: 11070114
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differentiation between phyllodes tumor and fibroadenoma using real-time elastography.
    Adamietz BR; Kahmann L; Fasching PA; Schulz-Wendtland R; Uder M; Beckmann MW; Meier-Meitinger M
    Ultraschall Med; 2011 Dec; 32 Suppl 2():E75-9. PubMed ID: 22194044
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nuclear survivin expression in stromal cells of phyllodes tumors and fibroadenomas of the breast.
    Hirano H; Matsushita K; Okimura A; Yoshida T; Kizaki T; Ito T
    Anticancer Res; 2014 Mar; 34(3):1251-3. PubMed ID: 24596368
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cystosarcoma phyllodes. Diagnosis by fine needle aspiration cytology.
    Rao CR; Narasimhamurthy NK; Jaganathan K; Mukherjee G; Hazarika D
    Acta Cytol; 1992; 36(2):203-7. PubMed ID: 1311887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phyllodes tumor. Fine needle aspiration cytology of eight cases.
    Shabb NS
    Acta Cytol; 1997; 41(2):321-6. PubMed ID: 9100761
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Radiomics Approach for the Classification of Fibroepithelial Lesions on Breast Ultrasonography.
    Sim Y; Lee SE; Kim EK; Kim S
    Ultrasound Med Biol; 2020 May; 46(5):1133-1141. PubMed ID: 32102739
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of histological features in needle core biopsy of breast useful in preoperative distinction between fibroadenoma and phyllodes tumour.
    Morgan JM; Douglas-Jones AG; Gupta SK
    Histopathology; 2010 Mar; 56(4):489-500. PubMed ID: 20459556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of clinical characteristics between benign borderline and malignant phyllodes tumors of the breast.
    Wang H; Wang X; Wang CF
    Asian Pac J Cancer Prev; 2014; 15(24):10791-5. PubMed ID: 25605178
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genome-wide analysis for loss of heterozygosity in primary and recurrent phyllodes tumor and fibroadenoma of breast using single nucleotide polymorphism arrays.
    Wang ZC; Buraimoh A; Iglehart JD; Richardson AL
    Breast Cancer Res Treat; 2006 Jun; 97(3):301-9. PubMed ID: 16791486
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Benign and low-grade fibroepithelial neoplasms of the breast have low recurrence rate after positive surgical margins.
    Cowan ML; Argani P; Cimino-Mathews A
    Mod Pathol; 2016 Mar; 29(3):259-65. PubMed ID: 26743469
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of Stromal Lesions.
    Yu J; Kansal K
    Surg Clin North Am; 2022 Dec; 102(6):1017-1030. PubMed ID: 36335922
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Precise diagnosis of breast phyllodes tumors using Raman spectroscopy: Biochemical fingerprint, tumor metabolism and possible mechanism.
    Wu Y; Wang Y; He C; Wang Y; Ma J; Lin Y; Zhou L; Xu S; Ye Y; Yin W; Ye J; Lu J
    Anal Chim Acta; 2023 Dec; 1283():341897. PubMed ID: 37977771
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fibroepithelial lesions of the breast with pleomorphic stromal giant cells: a clinicopathologic study of 4 cases and review of the literature.
    Huo L; Gilcrease MZ
    Ann Diagn Pathol; 2009 Aug; 13(4):226-32. PubMed ID: 19608080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.